PCRX

NASDAQStock

Pacira BioSciences, Inc.

$23.86+1.03 (+4.51%)

52-Week Range

$19.16
$27.22

Key Stats

Market Cap

1.0B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.23

Volume

542.1K

Avg Volume

994.2K

Performance

1M

+8.28%

3M

-11.81%

6M

-12.40%

YTD

-3.80%

1Y

+3.70%

3Y

-39.97%

5Y

-67.53%

Price Chart

ETF Exposure

PCRX is held by 123 ETFs

ETFFund NameWeight
DFAUDimensional - US Core Equity Market ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
IWViShares Russell 3000 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
SPTMState Street SPDR Portfolio S&P 1500 Composite Stock Market ETF0.00%
AVTMAvantis Total Equity Markets ETF 10.00%
DFUSDimensional - US Equity Market ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
MMTMState Street SPDR S&P 1500 Momentum Tilt ETF0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
AOAiShares Core 80/20 Aggressive Allocation ETF0.00%
AOKiShares Core 30/70 Conservative Allocation ETF0.00%
AOMiShares Core 40/60 Moderate Allocation ETF0.00%
AORiShares Core 60/40 Balanced Allocation ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
PreviousPage 3 of 3

About PCRX ETF Exposure

Pacira BioSciences, Inc. (PCRX) is held by 123 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.0B, PCRX is a widely held institutional stock. The stock currently trades at $23.86. Investors can gain exposure to PCRX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PCRX, sorted by portfolio weight.